Rim Sun Hee, Hall Ingrid J, Massetti Greta M, Thomas Cheryll C, Li Jun, Richardson Lisa C
Division of Cancer Prevention and Control, National Center for Chronic Disease Prevention and Health Promotion, Centers for Disease Control and Prevention, 4770 Buford Highway, NE, MS F-76, Atlanta, GA, 30341, USA.
J Cancer Educ. 2019 Aug;34(4):666-670. doi: 10.1007/s13187-018-1353-5.
Decision aids are tools intended to help people weigh the benefits and harms of a health decision. We examined primary care providers' perspective on use of decision aids and explored whether providers' beliefs and interest in use of a decision aid was associated with offering the prostate-specific antigen (PSA) test for early detection of prostate cancer. Data were obtained from 2016 DocStyles, an annual, web-based survey of U.S. healthcare professionals including primary care physicians (n = 1003) and nurse practitioners (n = 253). We found that the majority of primary care providers reported not using (patient) decision aids for prostate cancer screening, but were interested in learning about and incorporating these tools in their practice. Given the potential of decision aids to guide in informed decision-making, there is an opportunity for evaluating existing decision aids for prostate cancer screening for clinical use.
决策辅助工具是旨在帮助人们权衡健康决策利弊的工具。我们研究了初级保健提供者对使用决策辅助工具的看法,并探讨了提供者对使用决策辅助工具的信念和兴趣是否与提供前列腺特异性抗原(PSA)检测以早期发现前列腺癌有关。数据来自2016年DocStyles,这是一项针对美国医疗保健专业人员的年度网络调查,包括初级保健医生(n = 1003)和执业护士(n = 253)。我们发现,大多数初级保健提供者报告未使用(患者)决策辅助工具进行前列腺癌筛查,但有兴趣了解并将这些工具纳入他们的实践中。鉴于决策辅助工具在指导明智决策方面的潜力,有机会评估现有的前列腺癌筛查决策辅助工具以供临床使用。